Bioassay‐guided fractionation of lemon balm (Melissa officinalisL.) using anin vitromeasure of GABA transaminase activity
Citations Over TimeTop 10% of 2009 papers
Abstract
A novel pharmacological mechanism of action for the anxiolytic botanical Melissa officinalis L. (lemon balm) is reported. The methanol extract was identified as a potent in vitro inhibitor of rat brain GABA transaminase (GABA-T), an enzyme target in the therapy of anxiety, epilepsy and related neurological disorders. Bioassay-guided fractionation led to the identification and isolation of rosmarinic acid (RA) and the triterpenoids, ursolic acid (UA) and oleanolic acid (OA) as active principles. Phytochemical characterization of the crude extract determined RA as the major compound responsible for activity (40% inhibition at 100 microg/mL) since it represented approximately 1.5% of the dry mass of the leaves. Synergistic effects may also play a role.
Related Papers
- → α-Glucosidase enzyme inhibitory effects and ursolic and oleanolic acid contents of fourteen Anatolian Salvia species(2018)36 cited
- → Quantitative Analysis of Phenolic Acids and Antiplatelet Activity of Melissa officinalis Leaf Extracts(2017)10 cited
- Research on Method of Synchronization Analysis of Ursolic Acid and Oleanolic Acid in Ilex kudincha(2014)
- Comparison of Oleanolic Acid and Ursolic Acid in Loquat Leaves from Different Strains(2013)
- Extract and isolation of Oleanolic Acid and Ursolic Acid in Zelan(2003)